NASDAQ:CTKB

Cytek Biosciences, Inc.

Stock

USD

Last Close

4.54

06/11 22:03

Market Cap

733.82M

Beta: -

Volume Today

406.86K

Avg: 1.13M

PE Ratio

−73.77

PFCF: −132.08

Overview Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-16.83M -	19.41M 215.36%	3.03M 84.41%	2.48M 17.94%	-12.15M 589.05%
depreciation and amortization	309K -	603K 95.15%	1.24M 105.97%	5.66M 355.64%	9.23M 63.10%
deferred income tax		1.74M -	448K 74.31%		4.83M -
stock based compensation	269K -	611K 127.14%	6.59M 977.91%	16.59M 151.97%	22.05M 32.86%
change in working capital	1.16M -	-7.54M 750.78%	-8.65M 14.73%	-39.93M 361.81%	-10.51M 73.68%
accounts receivables	-12.61M -	334K 102.65%	-12.37M 3,802.69%	-19.74M 59.65%	-7.33M 62.86%
inventory	-14.61M -	-5.70M 60.97%	-7.07M 23.91%	-17.65M 149.76%	4.29M 124.28%
accounts payables	1.21M -	-55K 104.53%	-256K 365.45%	1.86M 827.34%	-1.78M 195.81%
other working capital	27.17M -	-2.11M 107.77%	11.04M 623.21%	-4.39M 139.77%	-5.68M 29.27%
other non cash items	1.34M -	323K 75.97%	1.97M 510.84%	2.96M 49.97%	-8.17M 376.11%
net cash provided by operating activities	-13.75M -	15.16M 210.25%	4.63M 69.45%	-12.23M 364.17%	5.28M 143.18%
investments in property plant and equipment	-973K -	-1.55M 58.99%	-4.36M 182.09%	-9.87M 126.12%	-4.83M 51.08%
acquisitions net			-16.63M -		-45.13M -
purchases of investments				-46.04M -	-175.94M 282.13%
sales maturities of investments					132M -
other investing activites
net cash used for investing activites	-973K -	-1.55M 58.99%	-20.99M 1,257.01%	-55.91M 166.32%	-93.89M 67.94%
debt repayment		-1.31M -	-2.77M 111.60%	-50K 98.20%	-565K 1,030%
common stock issued	93K -	119.83M 128,754.84%	215.69M 79.99%	1.20M 99.44%	1.47M 21.93%
common stock repurchased				-209K -	-44.15M 21,024.88%
dividends paid				-209K -	-1.47M 602.39%
other financing activites	93K -	4.08M 4,289.25%	642K 84.27%	4.78M 644.08%	2.90M 39.21%
net cash used provided by financing activities	93K -	122.61M 131,735.48%	213.56M 74.18%	5.51M 97.42%	-41.81M 858.43%
effect of forex changes on cash	-33K -	-587K 1,678.79%	1.30M 321.98%	-2.49M 291.17%	-1.45M 41.99%
net change in cash	-14.66M -	135.63M 1,025.16%	198.50M 46.35%	-65.12M 132.81%	-131.87M 102.51%
cash at beginning of period	45.15M -	30.49M 32.47%	166.12M 444.83%	364.62M 119.49%	299.50M 17.86%
cash at end of period	30.49M -	166.12M 444.83%	364.62M 119.49%	299.50M 17.86%	167.63M 44.03%
operating cash flow	-13.75M -	15.16M 210.25%	4.63M 69.45%	-12.23M 364.17%	5.28M 143.18%
capital expenditure	-973K -	-1.55M 58.99%	-4.36M 182.09%	-9.87M 126.12%	-4.83M 51.08%
free cash flow	-14.72M -	13.61M 192.45%	266K 98.05%	-22.10M 8,407.89%	454K 102.05%

All numbers in USD (except ratios and percentages)